Clinical Research ReportsFull Access
Published Online:1 Apr 2011
- Cited by
- 29 March 2024 | Current Opinion in Neurology, Vol. 76
- 16 December 2021 | DGNeurologie, Vol. 5, No. 1
- Multiple Sclerosis and Related Disorders, Vol. 51
- 31 March 2020 | Multiple Sclerosis Journal, Vol. 27, No. 1
- 23 June 2020 | Frontiers in Cellular Neuroscience, Vol. 14
- Multiple Sclerosis and Related Disorders, Vol. 41
- Multiple Sclerosis and Related Disorders, Vol. 40
- JAMA Neurology, Vol. 77, No. 1
- Neuroscience & Biobehavioral Reviews, Vol. 107
- 7 August 2018 | Multiple Sclerosis Journal, Vol. 25, No. 11
- 6 July 2018 | Multiple Sclerosis Journal, Vol. 25, No. 8
- 1 March 2019 | European Journal of Neurology, Vol. 26, No. 7
- 8 April 2019 | Neurogastroenterology & Motility, Vol. 31, No. 6
- 28 March 2018 | Multiple Sclerosis Journal, Vol. 25, No. 5
- 30 May 2018 | Annals of Neurology, Vol. 83, No. 6
- Adalia H. Jun-O’Connell,
M.D. , - Ankur Butala,
M.D. , - Idanis Berrios Morales,
M.D. , - Nils Henninger,
M.D. , - Kristina M. Deligiannidis,
M.D. , - Nancy Byatt,
D.O., M.S., M.B.A., FAPM. , - Carolina Ionete,
M.D., Ph.D.
19 August 2016 | The Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 29, No. 1- Adalia H. Jun-O’Connell,
- Journal of Thrombosis and Haemostasis, Vol. 12, No. 4
- 3 September 2013 | Translational Psychiatry, Vol. 3, No. 9
Metrics
This study is not industry-sponsored. Dr. Nancy Byatt reports no disclosures. Dr. Anthony Rothschild has received grants or funding from NIMH, Cyberonics, Takeda, and Wyeth, and has been a consultant for Pfizer, GlaxoSmithKline, Forest Laboratories, and Eli Lilly. He has received royalties from the Rothschild Scale for Antidepressant Tachyphylaxis (RSAT),TM and American Psychiatric Press, Inc. for Clinical Manual for Diagnosis and Treatment of Psychotic Depression, Evidence-Based Guide to Antipsychotic Medications. Dr. Peter Riskind has received honoraria and/or has consulted for Biogen Idec, and Teva Neurosciences. Dr. Carolina Ionete has consulted for Biogen Idec, TEVA, Serono, and Bayer. Dr. Anne Hunt reports no disclosures.
History
Received 5 April 2010
Revised 22 July 2010
Accepted 3 August 2010
Published online 1 April 2011
Published in print 1 April 2011